Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-13

FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for Metformin Hydrochloride from Zydus Lifesciences Limited, finalizing a change to this generic product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)